Global Immunocell Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immunocell Therapy market size was valued at US$ 1835.2 million in 2023. With growing demand in downstream market, the Immunocell Therapy is forecast to a readjusted size of US$ 4449.1 million by 2030 with a CAGR of 13.5% during review period.
The research report highlights the growth potential of the global Immunocell Therapy market. Immunocell Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immunocell Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immunocell Therapy market.
Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immunocell Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immunocell Therapy market. It may include historical data, market segmentation by Type (e.g., Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immunocell Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immunocell Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immunocell Therapy industry. This include advancements in Immunocell Therapy technology, Immunocell Therapy new entrants, Immunocell Therapy new investment, and other innovations that are shaping the future of Immunocell Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immunocell Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Immunocell Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immunocell Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immunocell Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immunocell Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immunocell Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immunocell Therapy market.
Market Segmentation:
Immunocell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Immunocell Therapy market size was valued at US$ 1835.2 million in 2023. With growing demand in downstream market, the Immunocell Therapy is forecast to a readjusted size of US$ 4449.1 million by 2030 with a CAGR of 13.5% during review period.
The research report highlights the growth potential of the global Immunocell Therapy market. Immunocell Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immunocell Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immunocell Therapy market.
Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Immunocell Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immunocell Therapy market. It may include historical data, market segmentation by Type (e.g., Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immunocell Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immunocell Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immunocell Therapy industry. This include advancements in Immunocell Therapy technology, Immunocell Therapy new entrants, Immunocell Therapy new investment, and other innovations that are shaping the future of Immunocell Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immunocell Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Immunocell Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immunocell Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immunocell Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immunocell Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immunocell Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immunocell Therapy market.
Market Segmentation:
Immunocell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Chimeric Antigen Receptor (CAR) T Cell Therapy
- Natural Killer (NK) Cell Therapy
- Others
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics (Pipeline)
- Autolus Therapeutics(Pipeline)
- Sorrento Therapeutics(Pipeline)
- Mustang Bio(Pipeline)
- Bluebird Bio(Pipeline)
- Cellectis(Pipeline)
- Allogene Therapeutics(Pipeline)
- Celyad(Pipeline)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunocell Therapy Market Size 2019-2030
2.1.2 Immunocell Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immunocell Therapy Segment by Type
2.2.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
2.2.2 Natural Killer (NK) Cell Therapy
2.2.3 Others
2.3 Immunocell Therapy Market Size by Type
2.3.1 Immunocell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immunocell Therapy Market Size Market Share by Type (2019-2024)
2.4 Immunocell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Immunocell Therapy Market Size by Application
2.5.1 Immunocell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immunocell Therapy Market Size Market Share by Application (2019-2024)
3 IMMUNOCELL THERAPY MARKET SIZE BY PLAYER
3.1 Immunocell Therapy Market Size Market Share by Players
3.1.1 Global Immunocell Therapy Revenue by Players (2019-2024)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immunocell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOCELL THERAPY BY REGIONS
4.1 Immunocell Therapy Market Size by Regions (2019-2024)
4.2 Americas Immunocell Therapy Market Size Growth (2019-2024)
4.3 APAC Immunocell Therapy Market Size Growth (2019-2024)
4.4 Europe Immunocell Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Immunocell Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immunocell Therapy Market Size by Country (2019-2024)
5.2 Americas Immunocell Therapy Market Size by Type (2019-2024)
5.3 Americas Immunocell Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunocell Therapy Market Size by Region (2019-2024)
6.2 APAC Immunocell Therapy Market Size by Type (2019-2024)
6.3 APAC Immunocell Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunocell Therapy by Country (2019-2024)
7.2 Europe Immunocell Therapy Market Size by Type (2019-2024)
7.3 Europe Immunocell Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunocell Therapy by Region (2019-2024)
8.2 Middle East & Africa Immunocell Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Immunocell Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOCELL THERAPY MARKET FORECAST
10.1 Global Immunocell Therapy Forecast by Regions (2025-2030)
10.1.1 Global Immunocell Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Immunocell Therapy Forecast
10.1.3 APAC Immunocell Therapy Forecast
10.1.4 Europe Immunocell Therapy Forecast
10.1.5 Middle East & Africa Immunocell Therapy Forecast
10.2 Americas Immunocell Therapy Forecast by Country (2025-2030)
10.2.1 United States Immunocell Therapy Market Forecast
10.2.2 Canada Immunocell Therapy Market Forecast
10.2.3 Mexico Immunocell Therapy Market Forecast
10.2.4 Brazil Immunocell Therapy Market Forecast
10.3 APAC Immunocell Therapy Forecast by Region (2025-2030)
10.3.1 China Immunocell Therapy Market Forecast
10.3.2 Japan Immunocell Therapy Market Forecast
10.3.3 Korea Immunocell Therapy Market Forecast
10.3.4 Southeast Asia Immunocell Therapy Market Forecast
10.3.5 India Immunocell Therapy Market Forecast
10.3.6 Australia Immunocell Therapy Market Forecast
10.4 Europe Immunocell Therapy Forecast by Country (2025-2030)
10.4.1 Germany Immunocell Therapy Market Forecast
10.4.2 France Immunocell Therapy Market Forecast
10.4.3 UK Immunocell Therapy Market Forecast
10.4.4 Italy Immunocell Therapy Market Forecast
10.4.5 Russia Immunocell Therapy Market Forecast
10.5 Middle East & Africa Immunocell Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Immunocell Therapy Market Forecast
10.5.2 South Africa Immunocell Therapy Market Forecast
10.5.3 Israel Immunocell Therapy Market Forecast
10.5.4 Turkey Immunocell Therapy Market Forecast
10.5.5 GCC Countries Immunocell Therapy Market Forecast
10.6 Global Immunocell Therapy Forecast by Type (2025-2030)
10.7 Global Immunocell Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Immunocell Therapy Product Offered
11.1.3 Novartis Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Immunocell Therapy Product Offered
11.2.3 Gilead Sciences Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immunocell Therapy Product Offered
11.3.3 Bristol-Myers Squibb Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Immunocell Therapy Product Offered
11.4.3 J & J Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Immunocell Therapy Product Offered
11.5.3 JW Therapeutics Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Immunocell Therapy Product Offered
11.6.3 FOSUNKite Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Information
11.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Information
11.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Information
11.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Offered
11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mustang Bio(Pipeline) Main Business Overview
11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Information
11.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bluebird Bio(Pipeline) Main Business Overview
11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Information
11.12.2 Cellectis(Pipeline) Immunocell Therapy Product Offered
11.12.3 Cellectis(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cellectis(Pipeline) Main Business Overview
11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Information
11.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Information
11.14.2 Celyad(Pipeline) Immunocell Therapy Product Offered
11.14.3 Celyad(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Celyad(Pipeline) Main Business Overview
11.14.5 Celyad(Pipeline) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunocell Therapy Market Size 2019-2030
2.1.2 Immunocell Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Immunocell Therapy Segment by Type
2.2.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
2.2.2 Natural Killer (NK) Cell Therapy
2.2.3 Others
2.3 Immunocell Therapy Market Size by Type
2.3.1 Immunocell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Immunocell Therapy Market Size Market Share by Type (2019-2024)
2.4 Immunocell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Immunocell Therapy Market Size by Application
2.5.1 Immunocell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Immunocell Therapy Market Size Market Share by Application (2019-2024)
3 IMMUNOCELL THERAPY MARKET SIZE BY PLAYER
3.1 Immunocell Therapy Market Size Market Share by Players
3.1.1 Global Immunocell Therapy Revenue by Players (2019-2024)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Immunocell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNOCELL THERAPY BY REGIONS
4.1 Immunocell Therapy Market Size by Regions (2019-2024)
4.2 Americas Immunocell Therapy Market Size Growth (2019-2024)
4.3 APAC Immunocell Therapy Market Size Growth (2019-2024)
4.4 Europe Immunocell Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Immunocell Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Immunocell Therapy Market Size by Country (2019-2024)
5.2 Americas Immunocell Therapy Market Size by Type (2019-2024)
5.3 Americas Immunocell Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunocell Therapy Market Size by Region (2019-2024)
6.2 APAC Immunocell Therapy Market Size by Type (2019-2024)
6.3 APAC Immunocell Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immunocell Therapy by Country (2019-2024)
7.2 Europe Immunocell Therapy Market Size by Type (2019-2024)
7.3 Europe Immunocell Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunocell Therapy by Region (2019-2024)
8.2 Middle East & Africa Immunocell Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Immunocell Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNOCELL THERAPY MARKET FORECAST
10.1 Global Immunocell Therapy Forecast by Regions (2025-2030)
10.1.1 Global Immunocell Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Immunocell Therapy Forecast
10.1.3 APAC Immunocell Therapy Forecast
10.1.4 Europe Immunocell Therapy Forecast
10.1.5 Middle East & Africa Immunocell Therapy Forecast
10.2 Americas Immunocell Therapy Forecast by Country (2025-2030)
10.2.1 United States Immunocell Therapy Market Forecast
10.2.2 Canada Immunocell Therapy Market Forecast
10.2.3 Mexico Immunocell Therapy Market Forecast
10.2.4 Brazil Immunocell Therapy Market Forecast
10.3 APAC Immunocell Therapy Forecast by Region (2025-2030)
10.3.1 China Immunocell Therapy Market Forecast
10.3.2 Japan Immunocell Therapy Market Forecast
10.3.3 Korea Immunocell Therapy Market Forecast
10.3.4 Southeast Asia Immunocell Therapy Market Forecast
10.3.5 India Immunocell Therapy Market Forecast
10.3.6 Australia Immunocell Therapy Market Forecast
10.4 Europe Immunocell Therapy Forecast by Country (2025-2030)
10.4.1 Germany Immunocell Therapy Market Forecast
10.4.2 France Immunocell Therapy Market Forecast
10.4.3 UK Immunocell Therapy Market Forecast
10.4.4 Italy Immunocell Therapy Market Forecast
10.4.5 Russia Immunocell Therapy Market Forecast
10.5 Middle East & Africa Immunocell Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Immunocell Therapy Market Forecast
10.5.2 South Africa Immunocell Therapy Market Forecast
10.5.3 Israel Immunocell Therapy Market Forecast
10.5.4 Turkey Immunocell Therapy Market Forecast
10.5.5 GCC Countries Immunocell Therapy Market Forecast
10.6 Global Immunocell Therapy Forecast by Type (2025-2030)
10.7 Global Immunocell Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Immunocell Therapy Product Offered
11.1.3 Novartis Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Immunocell Therapy Product Offered
11.2.3 Gilead Sciences Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immunocell Therapy Product Offered
11.3.3 Bristol-Myers Squibb Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Immunocell Therapy Product Offered
11.4.3 J & J Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Immunocell Therapy Product Offered
11.5.3 JW Therapeutics Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Immunocell Therapy Product Offered
11.6.3 FOSUNKite Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Information
11.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Information
11.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Information
11.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Offered
11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mustang Bio(Pipeline) Main Business Overview
11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Information
11.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Bluebird Bio(Pipeline) Main Business Overview
11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Information
11.12.2 Cellectis(Pipeline) Immunocell Therapy Product Offered
11.12.3 Cellectis(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cellectis(Pipeline) Main Business Overview
11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Information
11.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Information
11.14.2 Celyad(Pipeline) Immunocell Therapy Product Offered
11.14.3 Celyad(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Celyad(Pipeline) Main Business Overview
11.14.5 Celyad(Pipeline) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunocell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Major Players of Natural Killer (NK) Cell Therapy
Table 4. Major Players of Others
Table 5. Immunocell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 8. Immunocell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Immunocell Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Immunocell Therapy Revenue Market Share by Player (2019-2024)
Table 13. Immunocell Therapy Key Players Head office and Products Offered
Table 14. Immunocell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immunocell Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Immunocell Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Immunocell Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Immunocell Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Immunocell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Immunocell Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Immunocell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Immunocell Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Immunocell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Immunocell Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Immunocell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Immunocell Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Immunocell Therapy
Table 46. Key Market Challenges & Risks of Immunocell Therapy
Table 47. Key Industry Trends of Immunocell Therapy
Table 48. Global Immunocell Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Immunocell Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Immunocell Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Immunocell Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 53. Novartis Immunocell Therapy Product Offered
Table 54. Novartis Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Gilead Sciences Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 58. Gilead Sciences Immunocell Therapy Product Offered
Table 59. Gilead Sciences Main Business
Table 60. Gilead Sciences Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Gilead Sciences Latest Developments
Table 62. Bristol-Myers Squibb Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Immunocell Therapy Product Offered
Table 64. Bristol-Myers Squibb Main Business
Table 65. Bristol-Myers Squibb Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Latest Developments
Table 67. J & J Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 68. J & J Immunocell Therapy Product Offered
Table 69. J & J Main Business
Table 70. J & J Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. J & J Latest Developments
Table 72. JW Therapeutics Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 73. JW Therapeutics Immunocell Therapy Product Offered
Table 74. JW Therapeutics Main Business
Table 75. JW Therapeutics Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. JW Therapeutics Latest Developments
Table 77. FOSUNKite Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 78. FOSUNKite Immunocell Therapy Product Offered
Table 79. FOSUNKite Main Business
Table 80. FOSUNKite Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. FOSUNKite Latest Developments
Table 82. CARsgen Therapeutics (Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 83. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
Table 84. CARsgen Therapeutics (Pipeline) Main Business
Table 85. CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. CARsgen Therapeutics (Pipeline) Latest Developments
Table 87. Autolus Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 88. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 89. Autolus Therapeutics(Pipeline) Main Business
Table 90. Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Autolus Therapeutics(Pipeline) Latest Developments
Table 92. Sorrento Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 93. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 94. Sorrento Therapeutics(Pipeline) Main Business
Table 95. Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sorrento Therapeutics(Pipeline) Latest Developments
Table 97. Mustang Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 98. Mustang Bio(Pipeline) Immunocell Therapy Product Offered
Table 99. Mustang Bio(Pipeline) Main Business
Table 100. Mustang Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Mustang Bio(Pipeline) Latest Developments
Table 102. Bluebird Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 103. Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
Table 104. Bluebird Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Bluebird Bio(Pipeline) Main Business
Table 106. Bluebird Bio(Pipeline) Latest Developments
Table 107. Cellectis(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 108. Cellectis(Pipeline) Immunocell Therapy Product Offered
Table 109. Cellectis(Pipeline) Main Business
Table 110. Cellectis(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Cellectis(Pipeline) Latest Developments
Table 112. Allogene Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 113. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 114. Allogene Therapeutics(Pipeline) Main Business
Table 115. Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Allogene Therapeutics(Pipeline) Latest Developments
Table 117. Celyad(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 118. Celyad(Pipeline) Immunocell Therapy Product Offered
Table 119. Celyad(Pipeline) Main Business
Table 120. Celyad(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Celyad(Pipeline) Latest Developments
Table 1. Immunocell Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Major Players of Natural Killer (NK) Cell Therapy
Table 4. Major Players of Others
Table 5. Immunocell Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 8. Immunocell Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 11. Global Immunocell Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Immunocell Therapy Revenue Market Share by Player (2019-2024)
Table 13. Immunocell Therapy Key Players Head office and Products Offered
Table 14. Immunocell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immunocell Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Immunocell Therapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Immunocell Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Immunocell Therapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Immunocell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Immunocell Therapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Immunocell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Immunocell Therapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Immunocell Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Immunocell Therapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Immunocell Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Immunocell Therapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Immunocell Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Immunocell Therapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Immunocell Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Immunocell Therapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Immunocell Therapy
Table 46. Key Market Challenges & Risks of Immunocell Therapy
Table 47. Key Industry Trends of Immunocell Therapy
Table 48. Global Immunocell Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Immunocell Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Immunocell Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Immunocell Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 53. Novartis Immunocell Therapy Product Offered
Table 54. Novartis Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Gilead Sciences Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 58. Gilead Sciences Immunocell Therapy Product Offered
Table 59. Gilead Sciences Main Business
Table 60. Gilead Sciences Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Gilead Sciences Latest Developments
Table 62. Bristol-Myers Squibb Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 63. Bristol-Myers Squibb Immunocell Therapy Product Offered
Table 64. Bristol-Myers Squibb Main Business
Table 65. Bristol-Myers Squibb Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bristol-Myers Squibb Latest Developments
Table 67. J & J Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 68. J & J Immunocell Therapy Product Offered
Table 69. J & J Main Business
Table 70. J & J Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. J & J Latest Developments
Table 72. JW Therapeutics Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 73. JW Therapeutics Immunocell Therapy Product Offered
Table 74. JW Therapeutics Main Business
Table 75. JW Therapeutics Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. JW Therapeutics Latest Developments
Table 77. FOSUNKite Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 78. FOSUNKite Immunocell Therapy Product Offered
Table 79. FOSUNKite Main Business
Table 80. FOSUNKite Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. FOSUNKite Latest Developments
Table 82. CARsgen Therapeutics (Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 83. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
Table 84. CARsgen Therapeutics (Pipeline) Main Business
Table 85. CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. CARsgen Therapeutics (Pipeline) Latest Developments
Table 87. Autolus Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 88. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 89. Autolus Therapeutics(Pipeline) Main Business
Table 90. Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Autolus Therapeutics(Pipeline) Latest Developments
Table 92. Sorrento Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 93. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 94. Sorrento Therapeutics(Pipeline) Main Business
Table 95. Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sorrento Therapeutics(Pipeline) Latest Developments
Table 97. Mustang Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 98. Mustang Bio(Pipeline) Immunocell Therapy Product Offered
Table 99. Mustang Bio(Pipeline) Main Business
Table 100. Mustang Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Mustang Bio(Pipeline) Latest Developments
Table 102. Bluebird Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 103. Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
Table 104. Bluebird Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Bluebird Bio(Pipeline) Main Business
Table 106. Bluebird Bio(Pipeline) Latest Developments
Table 107. Cellectis(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 108. Cellectis(Pipeline) Immunocell Therapy Product Offered
Table 109. Cellectis(Pipeline) Main Business
Table 110. Cellectis(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Cellectis(Pipeline) Latest Developments
Table 112. Allogene Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 113. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 114. Allogene Therapeutics(Pipeline) Main Business
Table 115. Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Allogene Therapeutics(Pipeline) Latest Developments
Table 117. Celyad(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 118. Celyad(Pipeline) Immunocell Therapy Product Offered
Table 119. Celyad(Pipeline) Main Business
Table 120. Celyad(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Celyad(Pipeline) Latest Developments
LIST OF FIGURES
Figure 1. Immunocell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunocell Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immunocell Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immunocell Therapy Sales Market Share by Country/Region (2023)
Figure 8. Immunocell Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immunocell Therapy Market Size Market Share by Type in 2023
Figure 10. Immunocell Therapy in Hospitals
Figure 11. Global Immunocell Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immunocell Therapy in Clinics
Figure 13. Global Immunocell Therapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Immunocell Therapy in Others
Figure 15. Global Immunocell Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Immunocell Therapy Market Size Market Share by Application in 2023
Figure 17. Global Immunocell Therapy Revenue Market Share by Player in 2023
Figure 18. Global Immunocell Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immunocell Therapy Value Market Share by Country in 2023
Figure 24. United States Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immunocell Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Immunocell Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Immunocell Therapy Market Size Market Share by Application in 2023
Figure 31. China Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immunocell Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Immunocell Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immunocell Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immunocell Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immunocell Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immunocell Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Immunocell Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immunocell Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Immunocell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunocell Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Immunocell Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Immunocell Therapy Sales Market Share by Country/Region (2023)
Figure 8. Immunocell Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Immunocell Therapy Market Size Market Share by Type in 2023
Figure 10. Immunocell Therapy in Hospitals
Figure 11. Global Immunocell Therapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Immunocell Therapy in Clinics
Figure 13. Global Immunocell Therapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Immunocell Therapy in Others
Figure 15. Global Immunocell Therapy Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Immunocell Therapy Market Size Market Share by Application in 2023
Figure 17. Global Immunocell Therapy Revenue Market Share by Player in 2023
Figure 18. Global Immunocell Therapy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Immunocell Therapy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Immunocell Therapy Value Market Share by Country in 2023
Figure 24. United States Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Immunocell Therapy Market Size Market Share by Region in 2023
Figure 29. APAC Immunocell Therapy Market Size Market Share by Type in 2023
Figure 30. APAC Immunocell Therapy Market Size Market Share by Application in 2023
Figure 31. China Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Immunocell Therapy Market Size Market Share by Country in 2023
Figure 38. Europe Immunocell Therapy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Immunocell Therapy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Immunocell Therapy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Immunocell Therapy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Immunocell Therapy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Immunocell Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 57. United States Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 61. China Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 65. India Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 68. France Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 69. UK Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Immunocell Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Global Immunocell Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Immunocell Therapy Market Size Market Share Forecast by Application (2025-2030)
